Pertuzumab in HER2-positive breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Aboushawareb H, Mohamed AW, Alghzawi HM, Helbawy AE, Tarig A, Zatari H, Hekal MM, Hasan I, Shaban AY

DOI: 10.1007/s10549-026-08116-y
Published: 2026 Nov 9
Container: Breast cancer research and treatment
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10549-026-08116-y,
  title = {Pertuzumab in HER2-positive breast cancer: a systematic review and meta-analysis of randomized controlled trials.},
  author = {Aboushawareb H and Mohamed AW and Alghzawi HM and Helbawy AE and Tarig A and Zatari H and Hekal MM and Hasan I and Shaban AY},
  year = {2026},
  journal = {Breast cancer research and treatment},
  doi = {10.1007/s10549-026-08116-y},
  url = {https://doi.org/10.1007/s10549-026-08116-y}
}

RIS

TY  - JOUR
TI  - Pertuzumab in HER2-positive breast cancer: a systematic review and meta-analysis of randomized controlled trials.
AU  - Aboushawareb H
AU  - Mohamed AW
AU  - Alghzawi HM
AU  - Helbawy AE
AU  - Tarig A
AU  - Zatari H
AU  - Hekal MM
AU  - Hasan I
AU  - Shaban AY
PY  - 2026
JO  - Breast cancer research and treatment
DO  - 10.1007/s10549-026-08116-y
UR  - https://doi.org/10.1007/s10549-026-08116-y
ER  -

APA

H, A., AW, M., HM, A., AE, H., A, T., H, Z., MM, H., I, H., & AY, S. (2026). Pertuzumab in HER2-positive breast cancer: a systematic review and meta-analysis of randomized controlled trials.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-026-08116-y

Source records

pubmed · retrieved 2026-11-10T19:02:07.766Z